Supergut Investigation

Janove PLLC is investigating whether Supergut may have misleadingly marketed its GLP-1 Booster product as having benefits similar to GLP-1 agonist medications like Ozempic or Wegovy.

Get Started

What happened?

Have you purchased a GLP-1 Booster from Supergut?

You may be able to seek compensation in court.

We are investigating whether Supergut may have misled consumers with its marketing of the GLP-1 Booster product, including by comparing it to GLP-1 agonist medications like Ozempic or Wegovy. While Supergut claims that its supplement naturally boosts GLP-1 in the body, that may not be clinically proven. Further, the GLP-1 that a body may naturally create is not effective for facilitating weight loss or treating health conditions in the same manner as GLP-1 agonists such as Ozempic or Wegovy.

You have rights. If you have purchased a GLP-1 Booster product from Supergut, fill out our form below. Find out if you’re eligible to participate in a potential class action lawsuit.

Interest Form

To be considered as a class representative, please email a receipt or other documentation showing a Supergut GLP-1 Booster purchase to intake@janove.law.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

This website contains lawyer advertising. By submitting your information you acknowledge that it is subject to the policies described in our Privacy Policy and Disclaimers.

Class Action Lawsuit FAQs

Janove PLLC advocates for consumers, workers, and small business owners.

Contact Us

500 7th Ave., 8th Fl.
New York, NY 10018
T 646-347-3940  

1617 John F. Kennedy Blvd., 20th Fl.
Philadelphia, PA 19103
T 215-267-0100

979 Osos St., Ste. A5
San Luis Obispo, CA 93401
T 805-505-9550

info@janove.law

JANOVE PLLC
©2025. All Rights Reserved.
Privacy Policy and Disclaimers

This web site contains lawyer advertising.
Prior results do not guarantee a similar outcome.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.